/Companies

Paragon Biosciences Evozyne Capital

Chicago, US · Founded 2020 · Delaware LLC

Find your way into Paragon Biosciences Evozyne Capital

Sign up to see every warm intro you have to Paragon Biosciences Evozyne Capital

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Paragon Biosciences Evozyne Capital team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Founders & leadership

PJ
Patrick J. MorrisNamed on SEC filing
DP
Darien ParhadTreasurer

Reported raises · per SEC filings

Form D private placements

$9.5M disclosed across 1 round · 2020

▶$9.5MraisedMay 2020 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Darien ParhadExecutive Officer
  • Patrick J. MorrisExecutive Officer, Director
Offering amount
$9.5M
Amount sold
$9.5M
First sale
Apr 2020
Incorporated
Limited Liability Company, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has Paragon Biosciences Evozyne Capital raised?
Paragon Biosciences Evozyne Capital has disclosed $9.5M raised across 1 round.
Where is Paragon Biosciences Evozyne Capital headquartered?
Paragon Biosciences Evozyne Capital is headquartered in Chicago, US.